4 transcripts
ITCI
Earnings call transcript
NASDAQ
2024 Q3
30 Oct 24
with colleagues across the company, and I'm impressed with the high caliber of our talent. I believe we have the right strategy to grow CAPLYTA in its approved
ITCI
Earnings call transcript
NASDAQ
2024 Q2
7 Aug 24
of all, congratulations on a really nice quarter. I had a question on regulatory strategy in adjunctive MDD. You may not answer, but I was curious
ITCI
Earnings call transcript
NASDAQ
2024 Q1
7 May 24
501, coupled with lumateperone's distinct pharmacology reinforced our label expansion strategy and the long-term prospects for lumateperone across
ITCI
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
our regulatory and commercial strategy. Lastly, we plan to meet with the FDA later this year and discuss this important program with the agency.
We
- Prev
- 1
- Next